| For: | Echeverría N, Moratorio G, Cristina J, Moreno P. Hepatitis C virus genetic variability and evolution. World J Hepatol 2015; 7(6): 831-845 [PMID: 25937861 DOI: 10.4254/wjh.v7.i6.831] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i6/831.htm |
| Number | Citing Articles |
| 1 |
Václav Vopálenský, Anas Khawaja, Luděk Rožnovský, Jakub Mrázek, Tomáš Mašek, Martin Pospíšek. Characterization of Hepatitis C Virus IRES Quasispecies – From the Individual to the Pool. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00731
|
| 2 |
Zhiqing Wang, Isla Humphreys, Jocelyn Quistrebert, Haiting Chai, Robert Stass, Josh Dhir, Alexandru Nisioi, Paul Radford, Jonathan K. Ball, William L. Irving, Thomas A. Bowden, Paul Klenerman, Eleanor Barnes, Jane A. McKeating, Alexander W. Tarr, M. Azim Ansari. Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design. Cell Reports 2025; 44(10) doi: 10.1016/j.celrep.2025.116418
|
| 3 |
Nikolai Bessonov, Gennady Bocharov, Andreas Meyerhans, Vladimir Popov, Vitaly Volpert. Existence and Dynamics of Strains in a Nonlocal Reaction-Diffusion Model of Viral Evolution. SIAM Journal on Applied Mathematics 2021; 81(1) doi: 10.1137/19M1282234
|
| 4 |
Melina Farshbafnadi, Nima Rezaei. Handbook of Cancer and Immunology. 2024; doi: 10.1007/978-3-030-80962-1_125-1
|
| 5 |
Ana Ortega-Prieto, Marcus Dorner. Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. Vaccines 2017; 5(3) doi: 10.3390/vaccines5030024
|
| 6 |
Daniele Lapa, Anna Rosa Garbuglia, Maria Rosaria Capobianchi, Paola Del Porto. Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?. Cells 2019; 8(4) doi: 10.3390/cells8040305
|
| 7 |
Natalia Echeverría, Fabiana Gámbaro, Stéphanie Beaucourt, Martín Soñora, Nelia Hernández, Juan Cristina, Gonzalo Moratorio, Pilar Moreno. Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region. Viruses 2024; 16(4) doi: 10.3390/v16040560
|
| 8 |
Dimas Alexandre Kliemann, Cristiane Valle Tovo, Ana Beatriz Gorini da Veiga, Angelo Alves de Mattos, Charles Wood. Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database. World Journal of Gastroenterology 2016; 22(40): 8910-8917 doi: 10.3748/wjg.v22.i40.8910
|
| 9 |
Caroline E. R. Rowell, Hana M. Dobrovolny. Energy Requirements for Loss of Viral Infectivity. Food and Environmental Virology 2020; 12(4) doi: 10.1007/s12560-020-09439-9
|
| 10 |
Nian Ma, Dipayan Bose, Erle S. Robertson. Comprehensive Toxicology. 2026; doi: 10.1016/B978-0-323-95488-4.00114-5
|
| 11 |
Mengdi Qi, Mengmei Yang, Liangzi Xu, Chunli Ma, Pu Huang, Jing Sun, Jiandong Shi, Yunzhang Hu. Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019. Virus Research 2021; 296 doi: 10.1016/j.virusres.2021.198354
|
| 12 |
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
|
| 13 |
Melina Farshbafnadi, Nima Rezaei. Cancer and Surrounding Environment. Handbook of Cancer and Immunology 2025; 3 doi: 10.1007/978-3-032-00761-2_125
|
| 14 |
Rabaa Y. Athamneh, Rawan Abudalo, Malik Sallam, Abdelrahim Alqudah, Hasan Alquran, Kawther Faisal Amawi, Hashem A. Abu-Harirah. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes. Infection, Genetics and Evolution 2023; 109 doi: 10.1016/j.meegid.2023.105412
|
| 15 |
Rafid Jihad Albadr, Hayder Naji Sameer, Zainab H. Athab, Mohaned Adil, Ahmed Yaseen, Omer Qutaiba B. Allela. Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00269-2
|
| 16 |
Bushra Khubaib, Muhammad Idrees, Zareen Fatima, Madiha Akram, Samia Afzal, Iram Amin, Muhammad Shahid, Muhammad Wasim. Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome. Journal of Digestive Diseases 2017; 18(7) doi: 10.1111/1751-2980.12497
|
| 17 |
Lily He, Rui Dong, Rong Lucy He, Stephen S.-T. Yau. Positional Correlation Natural Vector: A Novel Method for Genome Comparison. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21113859
|
| 18 |
Hisashi Nakayama, Tadatoshi Takayama. Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World Journal of Hepatology 2015; 7(20): 2292-2302 doi: 10.4254/wjh.v7.i20.2292
|
| 19 |
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Annals of Hepatology 2022; 27 doi: 10.1016/j.aohep.2021.100649
|
| 20 |
Anton Eliseev, Keylie M. Gibson, Pavel Avdeyev, Dmitry Novik, Matthew L. Bendall, Marcos Pérez-Losada, Nikita Alexeev, Keith A. Crandall. Evaluation of haplotype callers for next-generation sequencing of viruses. Infection, Genetics and Evolution 2020; 82 doi: 10.1016/j.meegid.2020.104277
|
| 21 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1) doi: 10.3390/v15010214
|
| 22 |
Kimia Kamelian, Vincent Montoya, Andrea Olmstead, Winnie Dong, Richard Harrigan, Muhammad Morshed, Jeffrey B. Joy. Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52613-8
|
| 23 |
Joel Henrique Ellwanger, Valéria de Lima Kaminski, Jacqueline María Valverde-Villegas, Daniel Simon, Vagner Ricardo Lunge, José Artur Bogo Chies. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming. Infection, Genetics and Evolution 2018; 66 doi: 10.1016/j.meegid.2017.08.011
|
| 24 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; doi: 10.2174/9789815123432123010004
|
| 25 |
Noriyuki Watanabe, Takaya Suzuki, Tomoko Date, Hussein Aly Hussan, Su Su Hmwe, Hideki Aizaki, Masaya Sugiyama, Masashi Mizokami, William Delaney IV, Guofeng Cheng, Masamichi Muramatsu, Takaji Wakita. Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. Journal of General Virology 2020; 101(2) doi: 10.1099/jgv.0.001378
|
| 26 |
Luis Antonio Uribe-Noguez, José Antonio Mata-Marín, Alicia Ocaña-Mondragón, Ericka Nelly Pompa-Mera, Rosa María Ribas-Aparicio, Carla Ileana Arroyo-Anduiza, María Elena Gomez-Torres, Alberto Chaparro-Sánchez, Jesus Gaytán-Martínez, Stefan Mauss. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico. Journal of Infection and Chemotherapy 2020; 26(2) doi: 10.1016/j.jiac.2019.08.009
|
| 27 |
Mohamed El-Mesery, Mohammed El-Mowafy, Laila F. Youssef, Ahmed El-Mesery, Sally Yussef Abed, Abdelaziz Elgaml. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients. Journal of Interferon & Cytokine Research 2021; 41(2) doi: 10.1089/jir.2020.0118
|
| 28 |
James Palmer, Shahrzad Javadi, Stella Yao, Shymaa E. Bilasy, Ahmed El-Shamy. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00011-1
|
| 29 |
Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights 2024; 15(3) doi: 10.3390/gastroent15030049
|
| 30 |
Sayan Poddar, Rajarshi Roy, Parimal Kar.
The conformational dynamics of Hepatitis C Virus E2 glycoprotein with the increasing number of
N
-glycosylation unraveled by molecular dynamics simulations
. Journal of Biomolecular Structure and Dynamics 2025; 43(18) doi: 10.1080/07391102.2024.2319679
|
| 31 |
Pantazis I. Theotokis, Louise Usher, Christopher K. Kortschak, Ed Schwalbe, Sterghios A. Moschos. Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs. Molecular Therapy - Nucleic Acids 2017; 9 doi: 10.1016/j.omtn.2017.08.010
|
| 32 |
Samina Baig, Assel Berikkara, Ramsha Khalid, Syed A. Subhan, Tanveer Abbas, Syed Hani Abidi. In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation. Frontiers in Microbiology 2025; 15 doi: 10.3389/fmicb.2024.1498069
|
| 33 |
Santseharay Ramirez, Jens Bukh. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies. Antiviral Research 2018; 158 doi: 10.1016/j.antiviral.2018.07.014
|
| 34 |
Gokul Kalyanasundaram, James E. Feng, Frank Congiusta, Richard Iorio, Matthew DiCaprio, Afshin A. Anoushiravani. Treating Hepatitis C Before Total Knee Arthroplasty is Cost-Effective: A Markov Analysis. The Journal of Arthroplasty 2024; 39(2) doi: 10.1016/j.arth.2023.08.053
|
| 35 |
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America. 2017; doi: 10.1007/978-3-319-54567-7_17
|
| 36 |
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari, Piyush Kumar Gupta. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics 2023; 20(8) doi: 10.1021/acs.molpharmaceut.2c01080
|
| 37 |
Daniela Toma, Lucreția Anghel, Diana Patraș, Anamaria Ciubară. Hepatitis C Virus: Epidemiological Challenges and Global Strategies for Elimination. Viruses 2025; 17(8) doi: 10.3390/v17081069
|
| 38 |
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C Infection. Current Nutrition & Food Science 2021; 17(5) doi: 10.2174/1573401316999201009152726
|
| 39 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6) doi: 10.3390/microorganisms12061035
|
| 40 |
Mohamed E. Ali, Hamada M. Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El-Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents. Viruses 2021; 13(10) doi: 10.3390/v13102008
|
| 41 |
Kaho H. Tisthammer, Caroline Solis, Faye Orcales, Madu Nzerem, Ryan Winstead, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings, Lindi Wahl. Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus. PLOS Genetics 2022; 18(5) doi: 10.1371/journal.pgen.1010179
|
| 42 |
Sabina Velázquez-Márquez, Juan Núñez-Farfán. Pathogens Associated with the Development of Cancer in Humans. 2024; doi: 10.1007/978-3-031-62558-9_23
|
| 43 |
Darrick K. Li, Raymond T. Chung. Hepatitis C Virus Protocols. Methods in Molecular Biology 2019; 1911 doi: 10.1007/978-1-4939-8976-8_1
|
| 44 |
Lanhui Yang, Chenyan Jiang, Song Hu, Qiongni Diao, Jia Li, Wei Si, Mei Chen, Richard Zhao. Evolving Diversity of Hepatitis C Viruses in Yunnan Honghe, China. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030403
|
| 45 |
Asma Ahsan, Saira Dar, Fareeha Hassan, Farkhanda Ghafoor, Muhammad Haroon Yousuf, Syed Shahzad-ul-Hussan, Sripathi M Sureban. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0256816
|
| 46 |
Satoshi Kokura. Hyperthermic Oncology from Bench to Bedside. 2016; doi: 10.1007/978-981-10-0719-4_25
|
| 47 |
Evelyn Stelzl, Bernhard Haas, Bernd Bauer, Sherry Zhang, Ellen H. Fiss, Grantland Hillman, Aaron T. Hamilton, Rochak Mehta, Marintha L. Heil, Ed G. Marins, Brigitte I. Santner, Harald H. Kessler, Heiner Wedemeyer. First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0181273
|
| 48 |
Mohamed El-Mesery, Mohammed El-Mowafy, Abdelaziz Elgaml, Laila F. Youssef, Sally Y. Abed. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients. Journal of Interferon & Cytokine Research 2017; 37(8) doi: 10.1089/jir.2016.0128
|
| 49 |
Ilan S. Weisberg, Ira M. Jacobson. Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral Treatment. Clinics in Liver Disease 2017; 21(4) doi: 10.1016/j.cld.2017.06.007
|
| 50 |
Ali Moussaoui, Vitaly Volpert. The influence of immune cells on the existence of virus quasi-species. Mathematical Biosciences and Engineering 2023; 20(9) doi: 10.3934/mbe.2023710
|
| 51 |
Jun-Kyu Lee, Ji-Wan Choi, InWha Park, Na-Eun Kim, Hak Cheol Kwon, Jaeyoung Kwon, Yoon-Jae Song. Roseoside Is a Bioactive Compound in Kirengeshoma koreana Nakai Extract with Potent In Vitro Antiviral Activity Against Hepatitis C Virus. Molecules 2024; 29(21) doi: 10.3390/molecules29215130
|
| 52 |
Waqas Gulzar, Zafar Niaz, Sami Ullah Mumtaz, Somia Iqtadar, Tayyeba Komal, Sajid AbaidUllah. Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a. Pakistan BioMedical Journal 2019; 2(1) doi: 10.52229/pbmj.v2i1.28
|
| 53 |
Elisabetta Loggi, Ranka Vukotic, Fabio Conti, Stefano Gitto, Pietro Andreone. Gold Standard Assays for the Monitoring of Patients With Chronic Hepatitis C. Future Virology 2018; 13(8) doi: 10.2217/fvl-2018-0032
|
| 54 |
Pauline Trémeaux, Alban Caporossi, Marie-Ange Thélu, Michael Blum, Vincent Leroy, Patrice Morand, Sylvie Larrat. Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges. Critical Reviews in Clinical Laboratory Sciences 2016; 53(5) doi: 10.3109/10408363.2016.1163663
|
| 55 |
Andrea Galli, Jens Bukh. Viral Fitness and Evolution. Current Topics in Microbiology and Immunology 2023; 439 doi: 10.1007/978-3-031-15640-3_7
|
| 56 |
Burak Demiralay, Tolga Can. Effective primer design for genotype and subtype detection of highly divergent viruses in large scale genome datasets. BMC Bioinformatics 2025; 26(1) doi: 10.1186/s12859-025-06251-9
|
| 57 |
Kaho H. Tisthammer, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings. Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a. Viruses 2021; 13(3) doi: 10.3390/v13030511
|
| 58 |
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology 2025; 602 doi: 10.1016/j.virol.2024.110307
|
| 59 |
Micaela Parra, Natalia Laufer, Julieta M. Manrique, Leandro R. Jones, Jorge Quarleri. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. BioMed Research International 2017; 2017 doi: 10.1155/2017/1728456
|
| 60 |
Anoop Kumar, Manoj Kumar Rajput, Deepika Paliwal, Aakanksha Yadav, Reba Chhabra, Surinder Singh. Genotyping & diagnostic methods for hepatitis C virus. Indian Journal of Medical Research 2018; 147(5) doi: 10.4103/ijmr.IJMR_1850_16
|
| 61 |
Asad Zia, Muhammad Ali, Hafsa Aziz, Muhammad Zia, Zabta Khan Shinwari, Abida Raza. A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan. Infectious Diseases of Poverty 2018; 7(1) doi: 10.1186/s40249-018-0386-7
|
| 62 |
Mohammad Amin Behzadi, Abdolvahab Alborzi, Gholamreza Pouladfar, Mehdi Dianatpour, Mazyar Ziyaeyan. Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector. Jundishapur Journal of Microbiology 2015; 8(11) doi: 10.5812/jjm.27355
|
| 63 |
Inderjeet Singh Bharaj, Gurkaranvir Singh, Ajit Singh Brar, Aayushi Kacheria, Jasraj Kahlon, Billal Mohmand, Aalam Sohal, Beeletsega T Yeneneh. Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis. World Journal of Virology 2025; 14(3): 108754 doi: 10.5501/wjv.v14.i3.108754
|
| 64 |
Miguel Angel Martinez, Sandra Franco. Antiviral Drug Discovery and Development. Advances in Experimental Medicine and Biology 2021; 1322 doi: 10.1007/978-981-16-0267-2_6
|
| 65 |
Dana Elkhalifa, Israa Al-Hashimi, Ala-Eddin Al Moustafa, Ashraf Khalil. A comprehensive review on the antiviral activities of chalcones. Journal of Drug Targeting 2021; 29(4) doi: 10.1080/1061186X.2020.1853759
|
| 66 |
Mohammed El-Mowafy, Abdelaziz Elgaml, Mohamed El-Mesery, Salma Sultan, Tamer A. E. Ahmed, Ahmed I. Gomaa, Mahmoud Aly, Walid Mottawea. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection. Biology 2021; 10(1) doi: 10.3390/biology10010055
|
| 67 |
Miguel A. Minaya, Travis L. Jensen, Johannes B. Goll, Maria Korom, Sree H. Datla, Robert B. Belshe, Lynda A. Morrison, Richard M. Longnecker. Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections. Journal of Virology 2017; 91(23) doi: 10.1128/JVI.00942-17
|
| 68 |
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatments. World Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
|
| 69 |
|
| 70 |
Seema Patel. In silico analysis of Hepatitis C virus (HCV) polyprotein domains and their comparison with other pathogens and allergens to gain insight on pathogenicity mechanisms. Computational Biology and Chemistry 2016; 65 doi: 10.1016/j.compbiolchem.2016.10.006
|
| 71 |
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
|
| 72 |
P. Muñoz de Rueda, S. M. Jiménez-Ruiz, R. Quiles, E. J. Pavón-Castillero, J. A. Muñoz-Gámez, J. Casado, A. Gila, A. Ruiz-Extremera, J. Salmerón. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15605-0
|
| 73 |
Shantanu Prakash, Suruchi Shukla, Vangala Ramakrishna, Amita Jain. Distribution of hepatitis C genotypes in Uttar Pradesh, India; rare genotype 4 detected. Journal of Medical Virology 2018; 90(12) doi: 10.1002/jmv.25277
|
| 74 |
Wei Zhan, Manish Muhuri, Phillip W. L. Tai, Guangping Gao. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.673699
|
| 75 |
Afshin A. Anoushiravani, Gokul Kalyanasundaram, James E. Feng, Frank Congiusta, Richard Iorio, Matthew R. DiCaprio. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis. The Journal of Arthroplasty 2023; 38(7) doi: 10.1016/j.arth.2023.02.067
|
| 76 |
Letitia Shunmugam, Mahmoud E. S. Soliman. Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition. RSC Advances 2018; 8(73) doi: 10.1039/C8RA07346E
|
| 77 |
Chin Pok Chan, Haruka Uemura, Tsz Ho Kwan, Ngai Sze Wong, Shinichi Oka, Denise Pui Chung Chan, Shui Shan Lee. Review on the molecular epidemiology of sexually acquired hepatitis C virus infection in the Asia‐Pacific region. Journal of the International AIDS Society 2020; 23(9) doi: 10.1002/jia2.25618
|
| 78 |
Sobia Manzoor, Umair Akhtar, Sidrah Naseem, Madiha Khalid, Misha Mazhar, Fahed Parvaiz, Saba Khaliq. Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus Infection. Viral Immunology 2016; 29(7) doi: 10.1089/vim.2016.0008
|
| 79 |
Mousumi Bora, M. Manu, Monu Karki. Exploring the mechanisms of interference, persistence and antiviral potential of defective interfering particles. Discover Viruses 2025; 2(1) doi: 10.1007/s44370-025-00007-y
|
| 80 |
Sanket Mukherjee, Akhil Kumar, Jasmine Samal, Ekta Gupta, Perumal Vivekanandan, Manoj B. Menon. Selective Depletion of ZAP-Binding CpG Motifs in HCV Evolution. Pathogens 2022; 12(1) doi: 10.3390/pathogens12010043
|
| 81 |
Vincent Montoya, Anita Y. M. Howe, Weiyan Y. Dong, Winnie Dong, Chanson J. Brumme, Andrea D. Olmstead, Kanna Hayashi, P. Richard Harrigan, Jeffrey B. Joy. Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88132-8
|
| 82 |
Amina Gul, Nabeela Zahid, Jawad Ahmed, Fazli Zahir, Imtiaz Ali Khan, Ijaz Ali. Molecular characterization of Hepatitis C virus 3a in Peshawar. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1488-0
|
| 83 |
Guillermo A. Ortiz, Hirsh D. Trivedi, Claudia Nader. Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12648
|
| 84 |
Taiki Yamashita, Haruhiko Takeda, Atsushi Takai, Soichi Arasawa, Fumiyasu Nakamura, Yoichi Mashimo, Miyuki Hozan, Shigeru Ohtsuru, Hiroshi Seno, Yoshihide Ueda, Akihiro Sekine. Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59397-2
|
| 85 |
Geon-Woo Kim, Aleem Siddiqui. N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition. Proceedings of the National Academy of Sciences 2021; 118(10) doi: 10.1073/pnas.2022024118
|
| 86 |
Nadia Marascio, Salvatore Rotundo, Angela Quirino, Giovanni Matera, Maria Carla Liberto, Chiara Costa, Alessandro Russo, Enrico Maria Trecarichi, Carlo Torti. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice . World Journal of Gastroenterology 2022; 28(12): 1226-1238 doi: 10.3748/wjg.v28.i12.1226
|
| 87 |
Anders Boyd, Léa Duchesne, Karine Lacombe. Research gaps in viral hepatitis. Journal of the International AIDS Society 2018; 21(S2) doi: 10.1002/jia2.25054
|
| 88 |
Jing Zhao, Ye Zhao, Guozhong Zhang. Key Aspects of Coronavirus Avian Infectious Bronchitis Virus. Pathogens 2023; 12(5) doi: 10.3390/pathogens12050698
|
| 89 |
Світлана Іванівна Романюк, Сергій Васильович Комісаренко. Як відкрили вірус гепатиту С, або детективні пошуки вірусологів «мовчазного вбивці» . Visnik Nacional noi academii nauk Ukrai ni 2023; (12) doi: 10.15407/visn2020.12.003
|
| 90 |
Hadas Dvory‐Sobol, Bin Han, Julia Lu, Mei Yu, Rudolf K. Beran, Guofeng Cheng, Ross Martin, Evguenia Svarovskaia, Hongmei Mo. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Journal of Viral Hepatitis 2019; 26(8) doi: 10.1111/jvh.13116
|
| 91 |
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions in NS3, NS5A, and NS5B genes. Reviews in Medical Virology 2020; 30(4) doi: 10.1002/rmv.2120
|
| 92 |
Nobuyuki Kato. Hepatitis C virus (HCV)：Diversity and variation of RNA genome. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 2020; 132(2) doi: 10.4044/joma.132.60
|
| 93 |
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives. Current Issues in Molecular Biology 2023; 45(10) doi: 10.3390/cimb45100521
|
| 94 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1) doi: 10.3390/vaccines8010090
|
| 95 |
Arun K. Bhunia. Foodborne Microbial Pathogens. Food Science Text Series 2018; doi: 10.1007/978-1-4939-7349-1_6
|
| 96 |
Ximenya Glauce da Cunha Freire Lopes, Roque Ribeiro da Silva Júnior, Fernando Liberalino Fernandes, Laura Andrade Custódio de Oliveira, Vania Sousa Andrade, Fabiana Lima Bezerra, Josélio Maria Galvão de Araújo, Jenner Chrystian Veríssimo de Azevedo, Thales Allyrio Araújo de Medeiros Fernandes, José Veríssimo Fernandes. Epigenetic Mechanisms Involved in Hcv Infection and Human HCC. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262412045
|
| 97 |
Julia Durzyńska, Anna Goździcka-Józefiak. Viruses and cells intertwined since the dawn of evolution. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0400-7
|